Pronóstico del mercado de vacunas a base de plantas de América del Norte hasta 2028: impacto de COVID-19 y análisis regional por tipo de vacuna (vacunas bacterianas, vacunas virales, vacunas parasitarias y otras), fuente (planta de tabaco, maíz, papa y otras) y aplicación (Influenza, virus Zika, virus Ébola, enfermedades avícolas y otras)
Introducción al mercado
El mercado de vacunas de origen vegetal de América del Norte se divide en EE. UU., Canadá y México. Es probable que América del Norte capte una parte significativa del mercado global en 2021. Los factores clave que están impulsando el crecimiento del mercado son el creciente número de lanzamientos de productos junto con el impulso de las actividades de investigación y desarrollo. Sin embargo, durante el período de pronóstico es probable que el mercado se vea restringido por factores como los desafíos asociados con la aprobación del producto y los riesgos ambientales y de contaminación para la fabricación de vacunas de origen vegetal.
< span>América del Norte es una de las regiones más importantes para la adopción y crecimiento de nuevas tecnologías debido a políticas gubernamentales halagadoras para impulsar la innovación, la presencia de una enorme base industrial y el alto poder adquisitivo de los consumidores, principalmente en países importantes como el Estados Unidos y Canadá. Por lo tanto, cualquier impacto en el crecimiento de las industrias afecta negativamente el crecimiento económico de la región. Estados Unidos es el país más afectado del mundo debido al brote de COVID-19. Estados Unidos es un mercado eminente de vacunas de origen vegetal, ya que los principales actores del mercado se encuentran en ese país. Los cierres de fábricas y negocios en EE. UU., Canadá y México impactaron negativamente a varias industrias en 2020. Por otro lado, la pandemia ha ofrecido oportunidades de crecimiento vitales para los actores que operan en el mercado de vacunas de origen vegetal debido al creciente número de casos de COVID-19. 19 pacientes. Por ejemplo, varias empresas están llevando a cabo investigación y desarrollo para la creación de vacunas contra el COVID-19 basadas en plantas. Por ejemplo, en junio de 2021, iBio, una organización innovadora en biotecnología y fabricación por contrato de productos biológicos, anunció que los estudios preclínicos de IBIO-202, su candidata a vacuna de subunidad que se dirige a la proteína de la nucleocápside (“proteína N”) del SARS-CoV-2, demostró una respuesta sólida, específica de antígeno y de células T de memoria. El desarrollo de vacunas de origen vegetal impulsa el crecimiento del mercado.
Descripción general y dinámica del mercado
Se espera que el mercado de vacunas de origen vegetal en América del Norte crezca de 498,66 millones de dólares en 2021 a 1.181,06 millones de dólares en 2028; se estima que crecerá a una tasa compuesta anual del 13,1% de 2021 a 2028. Los trastornos o enfermedades infecciosas son causados por microorganismos patógenos como bacterias, virus, parásitos u hongos, y pueden transmitirse de una persona a otra directa o indirectamente. . Estas enfermedades se pueden dividir en tres categorías: enfermedades que causan altos niveles de mortalidad, enfermedades que infligen una gran carga de discapacidad a las poblaciones y enfermedades que, debido a su rápida e inesperada propagación, pueden tener consecuencias graves. Muchos de los principales factores de salud y causas de enfermedades infecciosas están fuera del control directo del sector de la salud. Otros sectores involucrados son el saneamiento y el suministro de agua, el cambio ambiental y climático, la educación, la agricultura, el comercio, el turismo, el transporte, el desarrollo industrial y la vivienda.
Segmentos de mercado clave
Norte El mercado estadounidense de vacunas a base de plantas está segmentado por tipo de vacuna, fuente, aplicación y país. Según el tipo de vacuna, el mercado de vacunas a base de plantas de América del Norte se segmenta en vacunas bacterianas, vacunas virales, vacunas parasitarias, partículas similares a virus de origen vegetal y otras. El segmento de vacunas bacterianas tuvo la mayor participación del mercado en 2021. Según la fuente, el mercado de vacunas a base de plantas de América del Norte está segmentado en plantas de tabaco, maíz, papa y otros. El segmento de plantas de tabaco tuvo la mayor participación del mercado en 2021. Según la aplicación, el mercado de vacunas a base de plantas de América del Norte se segmenta en influenza, virus zika, virus del Ébola, enfermedades avícolas, COVID-19 y otros. El segmento de influenza tuvo la mayor participación del mercado en 2021. Según el país, el mercado de vacunas a base de plantas de América del Norte está segmentado en EE. UU., Canadá y México. EE. UU. tuvo la mayor cuota de mercado en 2021.
Principales fuentes y empresas cotizadas
Algunas de las principales fuentes primarias y secundarias a las que se hace referencia para preparar este informe sobre el mercado de vacunas de origen vegetal en América del Norte son los sitios web de las empresas, los informes anuales, los informes financieros, los documentos del gobierno nacional y las bases de datos estadísticas, entre otros. . Las principales empresas que figuran en el informe son British American Tobacco plc; Biolabs creativos, Inc.; Fraunhofer; iBio, Inc.; Sistemas de expresión de hojas Ltd.; LenioBio; Lumen Biociencia, Inc.; Medicago, Inc.; y ZYUS Life Sciences Inc.
Informe de razones para comprar
- Comprender el panorama del mercado de vacunas a base de plantas de América del Norte e identificar los segmentos del mercado que son es más probable que garantice un fuerte retorno.
- Manténgase a la vanguardia al comprender el panorama competitivo en constante cambio para el mercado de vacunas de origen vegetal de América del Norte.
- Planifique de manera eficiente fusiones y adquisiciones y acuerdos de asociación en el mercado de vacunas de origen vegetal de América del Norte identificando segmentos de mercado con las ventas probables más prometedoras.
- Ayuda tomar decisiones comerciales informadas a partir de un análisis perspicaz y completo del desempeño del mercado de varios segmentos del mercado de vacunas a base de plantas de América del Norte.
- Obtener pronósticos de ingresos de mercado para varios segmentos a partir de 2021 -2028 en la región de América del Norte.
América del Norte Mercado de vacunas de origen vegetal Segmentación
Mercado de vacunas de origen vegetal de América del Norte - Por tipo de vacuna
- Vacunas bacterianas
- Vacunas virales
- Vacunas contra parásitos
- Partículas similares a virus de origen vegetal
- Otros
Mercado de vacunas de origen vegetal en América del Norte - Por Fuente
- Planta de tabaco
- Maíz
- Patata
- Otros
Norteamérica De origen vegetal Mercado de vacunas: por aplicación
- Influenza
- Virus Zika
- Virus del Ébola
- COVID-19
- Enfermedad de las aves de corral
- Otros
Mercado de vacunas de origen vegetal en América del Norte: por país
- EE.UU.
- Canadá
- México
Mercado de vacunas de origen vegetal en América del Norte: perfiles de empresas
- British American Tobacco plc
- Creative Biolabs, Inc.
- Fraunhofer
- iBio, Inc.
- Leaf Expression Systems Ltd.
- < span>LenioBio
- Lumen Bioscience, Inc.
- Medicago, Inc.
- ZYUS Life Sciences Inc.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Plant-based Vaccines Market – By Vaccine Type
1.3.2 North America Plant-based Vaccines Market – By Source
1.3.3 North America Plant-based Vaccines Market – By Application
1.3.4 North America Plant-based Vaccines Market – By Country
2. North America Plant-based Vaccines Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Plant-based Vaccines Market– Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Plant-based Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Plant-Based Vaccines Witnessing Rising Number of Research & Development (R&D) Activities
5.1.2 Rising Instances of Infectious Diseases
5.2 Market Restraints
5.2.1 High Risk of Contamination Including Environmental Risks for Manufacturing Plant-Based Vaccines
5.3 Market Opportunities
5.3.1 Enhancements in Production of Plant-Based Vaccines
5.4 Future Trends
5.4.1 Rise in Product Approvals and Increase in Prevalence of Infectious Diseases
5.5 Impact Analysis
6. Plant-based Vaccines Market– North America Analysis
6.1 North America Plant-based Vaccines Market Revenue Forecast and Analysis
7. North America Plant-Based Vaccines Market Analysis – By Vaccine Type
7.1 Overview
7.2 North America Plant-based Vaccines Market Revenue Share, by Vaccine Type (2021 and 2028)
7.3 Bacterial Vaccines
7.3.1 Overview
7.3.2 Bacterial Vaccines: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
7.4 Viral Vaccines
7.4.1 Overview
7.4.2 Viral Vaccines: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
7.5 Parasite Vaccines
7.5.1 Overview
7.5.2 Parasite Vaccines: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
7.6 Plant-derived Virus-like Particles (VLPs)
7.6.1 Overview
7.6.2 Plant-derived Virus-like particles (VLPs): Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
7.7 Others
7.7.1 Overview
7.7.2 Others: Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Plant-based Vaccines Market Analysis – By Source
8.1 Overview
8.2 North America Plant-based Vaccines Market Revenue Share, by Source (2021 and 2028)
8.3 Tobacco Plant
8.3.1 Overview
8.3.2 Tobacco Plant: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
8.4 Maize
8.4.1 Overview
8.4.2 Maize: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
8.5 Potato
8.5.1 Overview
8.5.2 Potato: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
8.6 Others
8.6.1 Overview
8.6.2 Others: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9. North America Plant-based Vaccines Market Analysis– by Application
9.1 Overview
9.2 North America Plant-based Vaccines Market Revenue Share, by Application (2021 and 2028)
9.3 Influenza
9.3.1 Overview
9.3.2 Influenza: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.4 Zika Virus
9.4.1 Overview
9.4.2 Zika Virus: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.5 Ebola Virus
9.5.1 Overview
9.5.2 Ebola Virus: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.6 Poultry Disease
9.6.1 Overview
9.6.2 Poultry Disease: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.7 Covid-19
9.7.1 Overview
9.7.2 Covid-19: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.8 Others
9.8.1 Overview
9.8.2 Others: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
10. North America Plant-based Vaccines Market – Country Analysis
10.1 North America: Plant based vaccines Market
10.1.1 Overview
10.1.2 North America: Plant-Based Vaccines Market, by Country, 2021 & 2028 (%)
10.1.2.1 US: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 US: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2 US Plant-Based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3 US Plant-Based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.4 US Plant-Based Vaccines Market, by Application– Revenue and Forecast to 2028 (USD Million)
10.1.2.2 Canada: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Canada: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2 Canada Plant-Based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3 Canada Plant-Based Vaccines Market, by Source– Revenue and Forecast to 2028 (USD Million)
10.1.2.2.4 Canada Plant-Based Vaccines Market, by Application– Revenue and Forecast to 2028 (USD Million)
10.1.2.3 Mexico: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 Mexico: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2 Mexico Plant-Based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3 Mexico Plant-Based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.4 Mexico Plant-Based Vaccines Market, by Application– Revenue and Forecast to 2028 (USD Million)
11. Impact Of COVID-19 Pandemic On North America Plant-based Vaccines Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Plant-based Vaccines Market –Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Plant-based Vaccines Market, 2019-2021
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 MEDICAGO, INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 British American Tobacco p.l.c.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 CREATIVE BIOLABS, INC.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 iBio, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 LENIOBIO
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Lumen Bioscience, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 LEAF EXPRESSION SYSTEMS LTD.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 ZYUS LIFE SCIENCES INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 FRAUNHOFER CMB
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. US Plant-Based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 2. US Plant-Based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 3. US Plant-Based Vaccines Devices Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 4. Canada Plant-Based Vaccines Market, by Vaccine Type -Revenue and Forecast to 2028 (USD Million)
Table 5. Canada Plant-Based Vaccines Market, by Source - Revenue and Forecast to 2028 (USD Million)
Table 6. Canada Plant-Based Vaccines Devices Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 7. Mexico Plant-Based Vaccines Market, by Vaccine Type -Revenue and Forecast to 2028 (USD Million)
Table 8. Mexico Plant-Based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 9. Mexico Plant-Based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 10. Recent organic developments in the Plant-based Vaccines Market
Table 11. Glossary of Terms, North America Plant-based Vaccines devices market
LIST OF FIGURES
Figure 1. North America Plant-based Vaccines Market Segmentation
Figure 2. North America Plant-based Vaccines Market Segmentation, By Country
Figure 3. North America Plant-based Vaccines Market Overview
Figure 4. Bacterial Vaccines Held the Largest Share of the Vaccine Type Segment in North America Plant-based Vaccines Market
Figure 5. US to Show Significant Growth during Forecast Period
Figure 7. North America PEST Analysis
Figure 8. North America Plant-Based Vaccines Market Impact Analysis of Driver and Restraints
Figure 9. North America Plant-based Vaccines Market– Revenue Forecast and Analysis – 2019- 2028
Figure 10. North America Plant-based Vaccines Market Revenue Share, by Vaccine Type (2021 and 2028)
Figure 11. North America Bacterial Vaccines: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. North America Viral Vaccines: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. North America Parasite Vaccines: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. North America Plant-derived Virus-like particles (VLPs): Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. North America Others: Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. North America Plant-based Vaccines Market Revenue Share, by Source (2021 and 2028)
Figure 17. North America Tobacco Plant: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. North America Maize: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. North America Potato: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. North America Others: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. North America Plant-based Vaccines Market Revenue Share, by Application (2021 and 2028)
Figure 22. North America Influenza: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. North America Zika Virus: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. North America Ebola Virus: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 25. North America Poultry Disease: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 26. North America Covid-19: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 27. North America Others: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 28. North America: Plant-Based Vaccines Market, by Key Country – Revenue (2021) (USD Million)
Figure 29. North America: Plant-Based Vaccines Market, by Country, 2021 & 2028 (%)
Figure 30. US: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. Canada: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Mexico: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. Impact of COVID-19 Pandemic in North American Country Markets
Figure 34. Growth Strategies in the Plant-based Vaccines Market, 2019-2021- British American Tobacco p.l.c.
- Creative Biolabs, Inc.
- Fraunhofer
- iBio, Inc.
- Leaf Expression Systems Ltd.
- LenioBio
- Lumen Bioscience, Inc.
- Medicago, Inc.
- ZYUS Life Sciences Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America plant-based vaccines market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America plant-based vaccines market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the plant-based vaccines market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution